genglob magazine


magazine by for generics, medicines and alternative treatments like ayurveda and traditional chinese

Treat Cancer Smarter With Molecular Profiling

Five words or lessMore than 1.5 million people in the United States will be diagnosed with cancer this year.
Of the many critical decisions they will have to make, none is more important than the type of treatment that will be used to fight their cancer — especially when patient response rates aren’t very promising.

First line or standard therapies for cancer fail, on average, at least 70 percent of the time, and, when they do, studies show that as few as 5 percent of cancer patients respond to the second standard treatment plan they are given.
However, a recent study in the Journal of Clinical Oncology showed that when 
molecular profiling was used to guide the selection of cancer therapy, a drug known to target the specific biomarkers of a tumor was found in 98 percent of advanced cancer patients studied. Read the rest of this entry »